August 7, 2020

The Niche

Knoepfler lab stem cell blog

ISSCR 2016

3 min read

Now that the ISSCR annual meeting is over, some overall stem cell trends are evident from the meeting in terms of the direction of the stem cell field. This was one of my favorite ISSCR meetings. Translation expectation and upbeat tone. The overall vibe at the meeting was a sense of excitement and optimism about the field and where it stands in terms of advancing knowledge and translating stem cells to the clinic. There are challenges and debates over the different possible paths forward, but the …Read More

3 min read

The second day of ISSCR 2016 started off with a great session on pluripotency and plasticity, and the first talk was by Shinya Yamanaka. He changed the title of his talk to “Reprogramming of Cells and Scientist”. As with my other posts on this meeting, this one is a stream of quotes and impressions from the talk. The beginning was more autobiographical on his part and then the second half was on basic science. I really enjoyed this talk overall. It’s now been a …Read More

3 min read

ISSCR 2016’s first plenary session is focused on stem cells & cancer. I was really excited about this one even before the meeting as this topic is a major focus of my own lab. Here’s the lineup for this plenary with great expertise in stem cells & cancer from across the globe: President’s Address: Sean Morrison, Children’s Research Institute at UT Southwestern, USA 2016 McEwen Award for Innovation Presentation: jointly, Austin Smith, Wellcome Trust Centre for Stem Cell Research and Institute for Stem Cell Biology, UK and Qi-Long Ying, …Read More

1 min read

Starting tomorrow I’m going to be at the ISSCR2016 meeting live blogging it in San Francisco. The annual ISSCR meeting is a great place to hear about all the latest research from basic findings to reports on pre-clinical and clinical studies. There are always valuable and unique insights from chatting with people too. I plan to report here on the latest science and policy developments including hopefully promising data on the goal of getting new stem cell therapies of various kinds moving from the lab …Read More